Golimumab

In the US, Golimumab (golimumab systemic) is a member of the drug class TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Psoriatic Arthritis and Rheumatoid Arthritis.

US matches:

• Golimumab


• Golimumab Subcutaneous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AB06

CAS registry number (Chemical Abstracts Service)

0476181-74-5

Chemical Formula

C6530-H10068-N1752-O2026-S44

Therapeutic Categories

Anti-inflammatory agent

Disease-modifying antirheumatic drug, DMARD

Immunomodulator

Foreign Names

• Golimumabum (Latin)
• Golimumab (German)
• Golimumab (French)
• Golimumab (Spanish)

Generic Names

• Golimumab (OS: USAN)
• CNTO 148 (IS)

Brand Names

• Simponi
  Centocor, United States; Essex, Germany; Schering-Plough, Australia; Schering-Plough, Canada; Schering-Plough, Sweden

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.